MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $180 | -4.8% | 237,292 | 0.0% | 0.00% | – |
Q1 2023 | $189 | +101.1% | 237,292 | 0.0% | 0.00% | – |
Q4 2022 | $94 | -100.0% | 237,292 | +0.0% | 0.00% | -100.0% |
Q3 2022 | $335,000 | +17.5% | 237,277 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $285,000 | -58.6% | 237,277 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $688,000 | -34.5% | 237,277 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $1,051,000 | -39.1% | 237,277 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $1,727,000 | -25.6% | 237,277 | 0.0% | 0.00% | -20.0% |
Q2 2021 | $2,321,000 | -17.4% | 237,277 | 0.0% | 0.01% | -28.6% |
Q1 2021 | $2,809,000 | +51.0% | 237,277 | 0.0% | 0.01% | +40.0% |
Q4 2020 | $1,860,000 | +15.3% | 237,277 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $1,613,000 | -9.5% | 237,277 | 0.0% | 0.01% | -16.7% |
Q2 2020 | $1,782,000 | +19.6% | 237,277 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $1,490,000 | -58.6% | 237,277 | 0.0% | 0.01% | -50.0% |
Q4 2019 | $3,597,000 | +47.8% | 237,277 | 0.0% | 0.01% | +33.3% |
Q3 2019 | $2,434,000 | -30.5% | 237,277 | 0.0% | 0.01% | -25.0% |
Q2 2019 | $3,500,000 | -10.4% | 237,277 | 0.0% | 0.01% | -20.0% |
Q1 2019 | $3,908,000 | +189.1% | 237,277 | 0.0% | 0.02% | +150.0% |
Q4 2018 | $1,352,000 | – | 237,277 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 8,008,204 | $94,817,000 | 34.93% |
Aquilo Capital Management, LLC | 2,502,210 | $29,626,000 | 5.35% |
Alphabet Inc. | 3,339,138 | $39,535,000 | 1.59% |
Casdin Capital, LLC | 3,346,034 | $39,617,000 | 1.18% |
Bleichroeder LP | 868,800 | $10,286,000 | 0.88% |
Altium Capital Management LP | 164,381 | $1,946,000 | 0.54% |
EcoR1 Capital, LLC | 556,354 | $6,587,000 | 0.29% |
Palo Alto Investors LP | 432,300 | $5,118,000 | 0.29% |
GILDER GAGNON HOWE & CO LLC | 4,189,412 | $49,603,000 | 0.27% |
HARVARD MANAGEMENT CO INC | 332,610 | $3,938,000 | 0.22% |